ZEISS have established a partnership with microbiome analytics firm Perseus Biomics. The partnership aims to develop an optical technology for microbiome research, specifically the quantitative analysis of the microbiome.
“The microbiome is a field of strong research interest with the potential to fundamentally change our understanding of living systems. Abundance analysis of the microbiome is one key element of this research and Perseus’ innovative optical technology has the potential to enable it at a new level,” said Gerrit Schulte, Head of ZEISS Ventures.
“We have assembled a first-class scientific and R&D team that aims to revolutionise microbiome analysis, making it faster, more precise and more affordable, while opening the way for broad-reach personalised medicine,” said Walid N. Hanna, Executive Chairman of Perseus.